Spinal Cord Stimulation and Training

Sponsor
Washington University School of Medicine (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05472584
Collaborator
(none)
120
1
6
59
2

Study Details

Study Description

Brief Summary

This study will help the investigators better understand the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal and spinal neural circuits and how the changes impact the improvements of spinal cord stimulation (SCS) mediated motor function.

Condition or Disease Intervention/Treatment Phase
  • Other: Electrophysiology assessment - corticospinal tract
  • Other: Electrophysiology assessment - reticulospinal tract
  • Other: Electrophysiology assessment - spinal motoneuron
  • Other: Activity-based training
  • Other: Transcutaneous spinal cord stimulation
N/A

Detailed Description

The goal of this project is to determine the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal, and spinal neural circuits that are involved in SCS-mediated motor function improvements in individuals with spinal cord injury (SCI). The study will: (1) Determine the short-term effects in neural excitability induced by SCS and activity-based training. (2) Determine the effect of motor training on short-term changes in neural excitability enabled by SCS. (3) Determine the long-term changes in motor control and neural plasticity induced by combined SCS and activity-based training in individuals with chronic SCI. Having a better understanding of the neural mechanisms that are enhanced by SCS can allow the development of therapies that directly target the excitability and plasticity states of these structures towards improved and accelerated recovery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Neural Plasticity by Spinal Cord Stimulation and Training in People With Spinal Cord Injury
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2027
Anticipated Study Completion Date :
Aug 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental: Non-invasive spinal cord stimulation

This arm will receive 30 minutes of transcutaneous spinal cord stimulation as participants rest.

Other: Electrophysiology assessment - corticospinal tract
Kinematics and cortical spinal motor excitability

Other: Electrophysiology assessment - reticulospinal tract
Kinematics and reticular spinal motor excitability

Other: Electrophysiology assessment - spinal motoneuron
Kinematics and spinal motoneuron excitability

Other: Transcutaneous spinal cord stimulation
Non-invasive spinal cord stimulation

Experimental: Experimental: Activity-based training

This arm will perform 30 minutes of activity-based training using leg movements.

Other: Electrophysiology assessment - corticospinal tract
Kinematics and cortical spinal motor excitability

Other: Electrophysiology assessment - reticulospinal tract
Kinematics and reticular spinal motor excitability

Other: Electrophysiology assessment - spinal motoneuron
Kinematics and spinal motoneuron excitability

Other: Activity-based training
Motor task

Experimental: Experimental: Activity-based training wtih non-invasive spinal cord stimulation

This arm will receive transcutaneous spinal cord stimulation as participants perform 30 minutes of activity-based training using leg movements.

Other: Electrophysiology assessment - corticospinal tract
Kinematics and cortical spinal motor excitability

Other: Electrophysiology assessment - reticulospinal tract
Kinematics and reticular spinal motor excitability

Other: Electrophysiology assessment - spinal motoneuron
Kinematics and spinal motoneuron excitability

Other: Activity-based training
Motor task

Other: Transcutaneous spinal cord stimulation
Non-invasive spinal cord stimulation

Experimental: Experimental: Non-invasive spinal cord stimulation and strength training

This arm will receive transcutaneous spinal cord stimulation as participants perform strengthening exercises.

Other: Electrophysiology assessment - corticospinal tract
Kinematics and cortical spinal motor excitability

Other: Electrophysiology assessment - reticulospinal tract
Kinematics and reticular spinal motor excitability

Other: Electrophysiology assessment - spinal motoneuron
Kinematics and spinal motoneuron excitability

Other: Activity-based training
Motor task

Other: Transcutaneous spinal cord stimulation
Non-invasive spinal cord stimulation

Experimental: Experimental: Non-invasive spinal cord stimulation and precision training

This arm will receive transcutaneous spinal cord stimulation as participants perform precision-control and dexterity exercises.

Other: Electrophysiology assessment - corticospinal tract
Kinematics and cortical spinal motor excitability

Other: Electrophysiology assessment - reticulospinal tract
Kinematics and reticular spinal motor excitability

Other: Electrophysiology assessment - spinal motoneuron
Kinematics and spinal motoneuron excitability

Other: Activity-based training
Motor task

Other: Transcutaneous spinal cord stimulation
Non-invasive spinal cord stimulation

Experimental: Experimental: Long-term activity-based training with non-invasive spinal cord stimulation

This arm will receive 4 weeks of activity-based training with transcutaneous spinal cord stimulation

Other: Electrophysiology assessment - corticospinal tract
Kinematics and cortical spinal motor excitability

Other: Electrophysiology assessment - reticulospinal tract
Kinematics and reticular spinal motor excitability

Other: Electrophysiology assessment - spinal motoneuron
Kinematics and spinal motoneuron excitability

Other: Activity-based training
Motor task

Other: Transcutaneous spinal cord stimulation
Non-invasive spinal cord stimulation

Outcome Measures

Primary Outcome Measures

  1. Motor evoked potentials amplitude and latency [30 minutes before and 30 minutes after intervention; 4 weeks]

    This primary outcome is a measure of changes in corticospinal tract excitability and plasticity as quantified by changes in the amplitude size and onset latency of motor evoked potentials elicited via transcranial magnetic stimulation.

  2. Reaction time to startle response [30 minutes before and 30 minutes after intervention; 4 weeks]

    This primary outcome is a measure of changes in reticulospinal tract excitability after training as quantified by changes in reaction time after a startling auditory stimulus.

  3. F-wave response persistence [30 minutes before and 30 minutes after intervention; 4 weeks]

    This primary outcome is a measure of changes in spinal motoneuron excitability as quantified by changes in the persistence of F-wave responses elicited via peripheral nerve stimulation.

Secondary Outcome Measures

  1. Changes in time to completion from baseline [Baseline, 30 minutes, and 4 weeks]

    Participants will perform cursor control as a computer game. This outcome measure is the time it takes participants to complete each task.

  2. Change in movement smoothness [Baseline, 30 minutes, and 4 weeks]

    This outcome is a measure of changes in movement smoothness when operating the computer cursor with the body.

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Healthy Volunteers

  • Age between 16 and 65 years old

  • Healthy people with no major comorbidities of any organ system

Exclusion Criteria:

Healthy Volunteers

  • Subjects younger than 16 or older than 65 years old

  • Subjects not providing consent or not able to consent

  • Subjects with any acute or chronic pain condition

  • Subjects with any acute or chronic disease of a major organ system

  • Use of analgesics within 24 hours prior to study period

  • Use of caffeine with 3 hours of study appointment

Inclusion criteria:

Participants with spinal cord injury (SCI)

  • Age between 16-65 years old

  • Traumatic SCI C4-T9 level, complete (ASIA A) or incomplete (ASIA B, C or D)

  • at least 1 year post injury

  • Stable medical condition

  • difficulty independently performing leg movements in routine activities

  • able to follow simple commands

  • able to speak and respond to questions

Exclusion criteria:

Participants with spinal cord injury (SCI)

  • Subjects younger than 16 or older than 65 years old

  • Not willing or able to provide consent

  • Any acute or chronic pain condition

  • Any acute or chronic disease of a major organ system

  • Use of analgesics within 24 hours prior to study appointment

  • Use of caffeine with 3 hours of study appointment

  • Presence of tremors, spasms and other significant involuntary movements

  • Etiology of SCI other than trauma

  • Concomitant neurologic disease (traumatic brain injury (TBI), multiple sclerosis (MS), stroke or peripheral neuropathy)

  • History of significant medical illness (cardiovascular disease, uncontrolled diabetes, uncontrolled hypertension, osteoporosis, cancer, chronic obstructive pulmonary disease, severe asthma requiring hospitalization for treatment, renal insufficiency requiring dialysis, autonomic dysreflexia, etc).

  • Severe joint contractures disabling or restricting lower limb movements.

  • Unhealed fracture, contracture, pressure sore, urinary tract infection or other uncontrolled infections, other illnesses that might interfere with lower extremity exercises or testing activities

  • Depression, anxiety, or cognitive impairment

  • Deficit of visuospatial orientation

  • Sitting tolerance less than 1 hour

  • Severe hearing or visual deficiency

  • Miss more than 3 appointments without notification

  • Unable to comply with any of the procedures in the protocol

  • Botulinum toxin injection in lower extremity muscles in the prior six months

  • Any passive implants (osteosynthesis material, metallic plates or screws) below T9.

  • Any implanted stimulator in the body (pacemaker, vagus nerve stimulator, etc.)

  • History of alcoholism or another drug abuse

  • Pregnancy (or possible pregnancy)

  • Having an Intrathecal Baclofen Therapy Pump (ITB pump)

  • History of epilepsy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Washington University Saint Louis Missouri United States 63105

Sponsors and Collaborators

  • Washington University School of Medicine

Investigators

  • Principal Investigator: Ismael Seanez, PhD, Washington University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ismael Seáñez, Assistant Professor of Biomedical Engineering and Neurosurgery, Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT05472584
Other Study ID Numbers:
  • 202206159
First Posted:
Jul 25, 2022
Last Update Posted:
Jul 25, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ismael Seáñez, Assistant Professor of Biomedical Engineering and Neurosurgery, Washington University School of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 25, 2022